دورية أكاديمية

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

التفاصيل البيبلوغرافية
العنوان: Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation
المؤلفون: Russano, Marco, Cortellini, Alessio, Giusti, Raffaele, Russo, Alessandro, Zoratto, Federica, Rastelli, Francesca, Gelibter, Alain, Chiari, Rita, Nigro, Olga, De Tursi, Michele, Bracarda, Sergio, Gori, Stefania, Grossi, Francesco, Bersanelli, MelissaAff14, Aff15, Calvetti, Lorenzo, Di Noia, Vincenzo, Scartozzi, Mario, Di Maio, Massimo, Bossi, Paolo, Falcone, Alfredo, Citarella, FabrizioAff1, IDs00262021030459_cor21, Pantano, Francesco, Ficorella, Corrado, Filetti, Marco, Adamo, Vincenzo, Veltri, Enzo, Pergolesi, Federica, Occhipinti, Mario Alberto, Nicolardi, Linda, Tuzi, Alessandro, Di Marino, Pietro, Macrini, Serena, Inno, Alessandro, Ghidini, Michele, Buti, SebastianoAff14, Aff15, Aprile, Giuseppe, Lai, Eleonora, Audisio, Marco, Intagliata, Salvatore, Marconcini, Riccardo, Brocco, Davide, Porzio, Giampiero, Piras, Marta, Rijavec, Erika, Simionato, Francesca, Natoli, Clara, Tiseo, MarcelloAff14, Aff15, Vincenzi, Bruno, Tonini, Giuseppe, Santini, Daniele
المصدر: Cancer Immunology, Immunotherapy. 71(4):865-874
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:03407004
14320851
DOI:10.1007/s00262-021-03045-9